MarketsandMarkets

ImmunoBio Series 2024 - West Coast Edition

08th - 09th February 2024

Double Tree by Hilton, San Diego - Mission Valley | 7450 Hazard Centre Drive San Diego, CA

Avail Your Ticket Avail
Your Ticket
Become A Sponsor Become
A Sponsor
Become A Speaker Become
A Speaker

EVENT OVERVIEW

Bridging Science, Innovation, and Health for a Better Tomorrow

MarketsandMarkets presents the Immunobio Series, an extraordinary trio of conferences taking place on 8-9 February 2024 in San Diego, California.

MarketsandMarkets 9th Annual Biomarker and Companion Diagnostics Conference:

Dive into the world of biomarkers at our flagship event, uniting experts and industry leaders to drive innovation in healthcare, diagnostics, and personalized medicine. Explore groundbreaking research and applications, fostering collaboration and knowledge sharing.

MarketsandMarkets 6th Annual Next Gen Microbiome and Probiotics Conference:

Discover the future of microbiome therapies and probiotics. Engage with professionals from diverse sectors to explore microbial innovation, regulatory pathways, and the vital microbiome-probiotics connection. Delve into cutting-edge research and strategies for successful commercialization.

MarketsandMarkets Next Gen Immuno-Oncology Conference:

Explore the forefront of cancer treatment at our inaugural Immuno-Oncology Conference. Join researchers and industry experts to discuss advancements in ADCs, Bispecific Antibodies, Cellular Therapy, and Immune Checkpoint Inhibitors. Participate in discussions, share insights, and shape the future of immuno-oncology.

Tag Line
Biomarker Discovery: Discussions on novel techniques and strategies for identifying new biomarkers, including genomics, proteomics, metabolomics, and bioinformatics. Precision Medicine: The role of biomarkers in tailoring treatments to individual patients for better efficacy and reduced side effects. Clinical Validation and Validation Strategies: Strategies for rigorously validating biomarkers for clinical use and addressing challenges in biomarker validation. Clinical Applications of Biomarkers: Cancer, Immunology, Neurodegenerative Disorders, Cardiovascular Biomarkers Bioinformatics and Data Analysis: Workshops and sessions on the analysis of biomarker data, including machine learning and artificial intelligence approaches. Biomarker-Based Diagnostics: Presentations on the development and commercialization of biomarker-based diagnostic tests and platforms. Collaborations and Industry Partnerships: Sessions on fostering collaboration between academia, industry, and government agencies to advance biomarker research.
Tag Line
Exploring the Function of the Gut Microbiome and Modulation of Immune Cells Role of human skin microbiome in precision health Modulating the GI Microbiome with Live Biotherapeutic Product to Enhance Efficacy of Cancer Immunotherapy Oral-Systemic Microbiome Connection and its Modulation Modulating the Vaginal Microbiome for Women’s Health and Fertility Mechanisms of Oncobiotic LBP Candidate in Enhancing Cancer Immunotherapy Microbiome as a science and its clinical applications- skin, gut & women’s health Prebiotics, Probiotics and Postbiotics Treating Clostridioides difficile: Microbiota-based Live Biotherapeutic Products to Provide the Answer  Microbiome’s Role in Cancer
Tag Line
Preclinical and Translational Immuno-Oncology Developments Next Gen Antibodies and Targeted Therapies Immune Checkpoint Inhibitors and Combination Therapies Tumor Microenvironment and Cancer Biomarkers CAR-T cell therapy, T Cell Therapy, Adoptive Cell Therapy Cancer Vaccines and Cancer Microbiome Personalizing Cancer Treatment- Challenges and Opportunities

Join us for this transformative event, where innovation meets collaboration, shaping the future of healthcare and biotechnology. MARKETSANDMARKETS IMMUNOBIO SERIES 2024- SAN DIEGO, CALIFORNIA

CO-LOCATED CONFERENCES

MarketsandMarkets Next-Gen Immuno-Oncology Conference - West Coast Edition
6th Annual MarketsandMarkets Next-Gen Microbiome and Probiotics Conference
9th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference - West Coast Edition

WHAT TO EXPECT

  • CUTTING-EDGE INSIGHTS: Access the latest advancements in biomarker discovery, precision medicine, and clinical applications spanning cancer, immunology, neurodegenerative disorders, and cardiovascular biomarkers.
  • MULTIDISCIPLINARY LEARNING: Gain a comprehensive understanding of microbiome and probiotics research, exploring diverse topics and practical applications across healthcare, biotechnology, and food production.
  • INNOVATIVE IMMUNOTHERAPY: Dive into immune-oncology projects, exploring antibodies, cellular therapy, and immune checkpoint research. Contribute to interactive discussions, share your work, and stay updated on cutting-edge technologies and platforms.
  • PROFESSIONAL DEVELOPMENT: Enhance your skills with workshops on biomarker data analysis, machine learning, and artificial intelligence applications. Learn best practices and methodologies for microbiome and probiotics research.
  • PRACTICAL APPLICATIONS: Discover how research translates into real-world applications. Explore exhibitor showcases, demonstrations, and case studies, gaining insights into the latest tools and technologies.
  • PERSONAL AND INDUSTRY GROWTH: Step out of your comfort zone, engage in interactive roundtables, and contribute to key discussions. Elevate your personal and professional growth within the dynamic fields of biomarker research, microbiome studies, and immunotherapy.

Immerse yourself in groundbreaking research, expand your network, and drive innovation at the Immunobio Series, where science meets collaboration.

Steam A - Biomarker and Companion Diagnostics Conference

Stream B - Next Gen Microbiome and Probiotics Conference

Stream C- Next Gen Immuno-Oncology Conference
  1. Biomarker Discovery: Discussions on novel techniques and strategies for identifying new biomarkers, including genomics, proteomics, metabolomics, and bioinformatics.
  2. Precision Medicine: The role of biomarkers in tailoring treatments to individual patients for better efficacy and reduced side effects.
  3. Clinical Validation and Validation Strategies: Strategies for rigorously validating biomarkers for clinical use and addressing challenges in biomarker validation.
  4. Clinical Applications of Biomarker: Cancer, Immunology, Neurodegenerative Disorders, Cardiovascular Biomarkers
  5. Bioinformatics and Data Analysis: Workshops and sessions on the analysis of biomarker data, including machine learning and artificial intelligence approaches.
  6. Biomarker-Based Diagnostics: Presentations on the development and commercialization of biomarker-based diagnostic tests and platforms.
  7. Collaborations and Industry Partnerships: Sessions on fostering collaboration between academia, industry, and government agencies to advance biomarker research.

 
  1. Exploring the Function of the Gut Microbiome and Modulation of Immune Cells
  2. Role of human skin microbiome in precision health
  3. Modulating the GI Microbiome with Live Biotherapeutic Product to Enhance Efficacy of Cancer Immunotherapy
  4. Oral-Systemic Microbiome Connection and its Modulation
  5. Modulating the Vaginal Microbiome for Women’s Health and Fertility
  6. Mechanisms of Oncobiotic LBP candidate in Enhancing Cancer Immunotherapy
  7. Microbiome as a science and its clinical applications- skin, gut & women’s health
  8. Prebiotics, Probiotics and Postbiotics
  9. Treating Clostridioides difficile: Microbiota-based Live Biotherapeutic Products to Provide the Answer
  10. Microbiome’s role in Cancer

 
  1. Preclinical and Translational Immuno-Oncology Developments
  2. Next Gen Antibodies and Targeted Therapies
  3. Immune Checkpoint Inhibitors and Combination Therapies
  4. Tumor Microenvironment and Cancer Biomarkers
  5. CAR-T cell therapy, T Cell Therapy, Adoptive Cell Therapy
  6. Cancer Vaccines and Cancer Microbiome
  7. Personalizing Cancer Treatment- Challenges and Opportunities

 

Expression #1 of SELECT list is not in GROUP BY clause and contains nonaggregated column 'cnceventswithcrm.s.id' which is not functionally dependent on columns in GROUP BY clause; this is incompatible with sql_mode=only_full_group_by